Literature DB >> 2899054

Chromosome localization and polymorphism of an oestrogen-inducible gene specifically expressed in some breast cancers.

J P Moisan1, M G Mattei, J L Mandel.   

Abstract

The BCEI gene codes for a small secreted protein and is expressed in the human mammary tumour cell line MCF7 under oestrogen control and in some breast cancers. We have mapped the gene to chromosome 21 using a panel of somatic hybrid lines, and in situ hybridization has allowed a precise assignment to band 21q223. Two restriction fragment length polymorphisms (RFLP) are described that should be of use in linkage or population studies to test a possible involvement of the BCEI gene in genetic predisposition to breast cancer. This gene should also be a useful marker for the genetic and physical mapping of chromosome 21, and for a better definition of the region involved in the clinical phenotype of Downs syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899054     DOI: 10.1007/bf00280558

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  Detection of specific RNAs or specific fragments of DNA by fractionation in gels and transfer to diazobenzyloxymethyl paper.

Authors:  J C Alwine; D J Kemp; B A Parker; J Reiser; J Renart; G R Stark; G M Wahl
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  Dispersed human immunoglobulin kappa light-chain genes.

Authors:  E Lötscher; K H Grzeschik; H G Bauer; H D Pohlenz; B Straubinger; H G Zachau
Journal:  Nature       Date:  1986 Apr 3-9       Impact factor: 49.962

3.  Characterization of a set of X-linked sequences and of a panel of somatic cell hybrids useful for the regional mapping of the human X chromosome.

Authors:  I Oberlé; G Camerino; C Kloepfer; J P Moisan; K H Grzeschik; B Hellkuhl; M C Hors-Cayla; N Van Cong; D Weil; J L Mandel
Journal:  Hum Genet       Date:  1986-01       Impact factor: 4.132

4.  Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome.

Authors:  J M Delabar; D Goldgaber; Y Lamour; A Nicole; J L Huret; J de Grouchy; P Brown; D C Gajdusek; P M Sinet
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

5.  Report of the Committee on Chromosome Rearrangements in Neoplasia and on Fragile Sites.

Authors:  R Berger; C D Bloomfield; G R Sutherland
Journal:  Cytogenet Cell Genet       Date:  1985

6.  Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7.

Authors:  S B Jakowlew; R Breathnach; J M Jeltsch; P Masiakowski; P Chambon
Journal:  Nucleic Acids Res       Date:  1984-03-26       Impact factor: 16.971

7.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line.

Authors:  P Masiakowski; R Breathnach; J Bloch; F Gannon; A Krust; P Chambon
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

8.  Trisomy 21 for the region 21q223: identification by high-resolution R-banding patterns.

Authors:  J F Mattei; M G Mattei; M A Baeteman; F Giraud
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

Review 9.  Genetics, biomarkers, and control of breast cancer: a review.

Authors:  H T Lynch; W A Albano; J J Heieck; G M Mulcahy; J F Lynch; M A Layton; B S Danes
Journal:  Cancer Genet Cytogenet       Date:  1984-09

10.  Down syndrome with duplication of a region of chromosome 21 containing the CuZn superoxide dismutase gene without detectable karyotypic abnormality.

Authors:  J L Huret; J M Delabar; F Marlhens; A Aurias; A Nicole; M Berthier; J Tanzer; P M Sinet
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

View more
  6 in total

Review 1.  Trefoil peptides.

Authors:  W M Wong; R Poulsom; N A Wright
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

2.  Changes of common fragile sites on chromosomes according to the menstrual cycle.

Authors:  T Furuya; J Hagiwara; H Ochi; H Tokuhiro; R Kikawada; T Karube; S Watanabe
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

3.  Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22.

Authors:  A E Lehesjoki; M Koskiniemi; P Sistonen; J Miao; J Hästbacka; R Norio; A de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

4.  pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival.

Authors:  A D Thor; F C Koerner; S M Edgerton; W C Wood; M A Stracher; L H Schwartz
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Expression of pS2 protein in breast cancer.

Authors:  G Crombach; A Ingenhorst; U J Göhring; A Scharl; W Neuhaus; V Möbus; H J Schaeffer
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

6.  pS2 is an independent factor of good prognosis in primary breast cancer.

Authors:  A M Thompson; R A Hawkins; R A Elton; C M Steel; U Chetty; D C Carter
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.